A retrospective study assessing effectiveness and safety of selinexor-based regimen in the treatment of relapsed and refractory multiple myeloma
Latest Information Update: 17 Aug 2022
At a glance
- Drugs Selinexor (Primary)
- Indications Multiple myeloma
- Focus Adverse reactions; Therapeutic Use
Most Recent Events
- 17 Aug 2022 New trial record